Investigating the role of IL-1 signaling in myelofibrosis
Targeting of IL-1 Signaling in Myelofibrosis
This study is looking at how a protein called IL-1 affects myelofibrosis, a serious blood condition, in hopes of finding new ways to treat it and help patients feel better.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Virginia NIH-funded |
| Lab location | 1 site (Charlottesville, United States) |
| Project ID | NIH-10804665 on NIH RePORTER |
What this research studies
This research focuses on understanding how IL-1 signaling contributes to myelofibrosis, a severe blood disorder characterized by the overproduction of blood cells. The study aims to explore new therapeutic targets by examining the effects of IL-1 on bone marrow fibrosis and blood counts in a mouse model. By targeting IL-1 signaling, the researchers hope to develop novel treatments that could improve patient outcomes. The approach includes genetic manipulation and analysis of blood and bone marrow samples to assess the impact of IL-1 inhibition.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with myelofibrosis or related myeloproliferative neoplasms.
Not a fit: Patients with other types of blood disorders not related to myelofibrosis may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that significantly improve the management and outcomes for patients with myelofibrosis.
How similar studies have performed: Preliminary studies have shown promising results in mouse models, indicating that targeting IL-1 signaling may be a viable approach for treating myelofibrosis.
Where this research is happening
Charlottesville, United States
- University of Virginia — Charlottesville, United States (Active)
Researchers
- Principal investigator: Mohi, Golam — University of Virginia
- Study coordinator: Mohi, Golam
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.